Apotea Balance Sheet Health

Financial Health criteria checks 5/6

Apotea has a total shareholder equity of SEK581.1M and total debt of SEK14.0M, which brings its debt-to-equity ratio to 2.4%. Its total assets and total liabilities are SEK1.5B and SEK922.5M respectively. Apotea's EBIT is SEK256.3M making its interest coverage ratio 91.5. It has cash and short-term investments of SEK12.1M.

Key information

2.4%

Debt to equity ratio

SEK 14.00m

Debt

Interest coverage ratio	91.5x
Cash	SEK 12.10m
Equity	SEK 581.10m
Total liabilities	SEK 922.50m
Total assets	SEK 1.50b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: APOTEA's short term assets (SEK943.1M) exceed its short term liabilities (SEK795.8M).

Long Term Liabilities: APOTEA's short term assets (SEK943.1M) exceed its long term liabilities (SEK126.7M).

Debt to Equity History and Analysis

Debt Level: APOTEA's net debt to equity ratio (0.3%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if APOTEA's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: APOTEA's debt is well covered by operating cash flow (1858.6%).

Interest Coverage: APOTEA's interest payments on its debt are well covered by EBIT (91.5x coverage).

Balance Sheet

Discover healthy companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/17 14:14
End of Day Share Price	2024/12/17 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Apotea AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution